Riskpilot← Back to searchSign inGet full accessFarmas Invest ApS
APSActiveCVR 40102817Fabriksvej 1Activities of holding companies · NACE 6421Est. 2018— employees
Revenue 2025
—
EBITDA margin
—
+110% vs 2024
Equity ratio
58.6%
Financial strength
Net profit 2025
DKK 2,6M
+198% vs 2024
| Revenue | — | — |
| EBITDA | DKK 3,3M | +110% |
| Net profit | DKK 2,6M | +198% |
| Total assets | DKK 58,8M | +5% |
| Equity | DKK 34,4M | +8% |
| Employees | — | — |
Legal name
Farmas Invest ApS
CVR number
40102817
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
17. december 2018
Share capital
DKK 660.000
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2025-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at drive virksomhed som holding- og investeringsselskab og gennem dat-terselskaber at drive handel og produktion.
Address
Fabriksvej 1
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | — | -10 | — | — | — |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 4.104 | -10 | 3.436 | 1.592 | 3.341 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | 4.104 | -10 | 3.436 | 1.592 | 3.341 |
| Net financials | 3.520 | 6.178 | 2.766 | 684 | 2.417 |
| Profit before tax | 3.510 | 6.168 | 2.559 | 673 | 2.406 |
| Tax | -133 | -147 | -201 | -205 | -208 |
| Net profit | 3.643 | 6.315 | 2.759 | 878 | 2.615 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 46.803 | 48.332 | 55.175 | 56.228 | 58.779 |
| Equity | 26.080 | 32.095 | 31.224 | 31.952 | 34.416 |
| Long-term debt | 15.609 | 13.494 | 11.016 | 10.897 | 12.321 |
| Short-term debt | 5.114 | 2.744 | 12.936 | 13.380 | 12.043 |
| Total debt | 20.723 | 16.237 | 23.951 | 24.277 | 24.363 |
EBITDA margin
334121600.0%
This company
15.8%
Market median
+2114693571% vs market
20212025
Equity ratio
58.6%
This company
38.2%
Market median
+53% vs market
20212025
Return on equity
7.6%
This company
18.4%
Market median
-59% vs market
20212025
Net profit margin
261450500.0%
This company
8.1%
Market median
+3227783851% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.71×
This company
0.62×
Market median
+15% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AR Management | Management | 2018 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 66.67–89.99% | 25–33.32% | 2022 | |
| Company | 25–33.32% | 10–14.99% | 2020 | |
| Company | 33.33–49.99% | 66.67–89.99% | 2020 | |
| Company | 15–19.99% | 5–9.99% | 2020 | |
| Company | 0% | 50–66.65% | 2022 | |
| Company | 15–19.99% | 5–9.99% | 2020 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
OR Invest Farsø ApS
Farmas Invest ApS Board members of Farmas Invest ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anette Rosengreen | Management | 0 companies |